WMWilliam R. Mills

William R. Mills

*This is an algorithmically generated author record based on publicly available information.

William R. Mills has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Novel Anti-Frailty Home Healthcare Program Improves Physical Performance Measures and Increases Independence in Frail Older Adults

    by William R. Mills, Renee Lach-Sharon, Sue T. Briggs, Alexa S. Mills, Stacy A. Bromell, Anthony Baker, Jennifer D. Hall, Josh Smitherman, Dmitri Poltavski

    Frailty is associated with an increase in mortality and unplanned hospitalization. We aimed to test the ability of a novel home healthcare program to reverse frailty in a geriatric home health population. We designed a home healthcare exercise program including aerobic, resistance, balance, and flexibility components (Vitality Therapy™, “VT”). We assessed physical performance measures in a frail cohort at baseline, and at multiple follow-up points. Between August 27, 2023 and May 31, 2024, 98 frail adults (35 males, 63 females; mean age 80 ± 10 years) participated in physical therapist-led exercise. The Short Physical Performance Battery (SPPB), the clinical frailty scale and level of ambulation assistance were assessed. Mixed linear modeling was used to perform statistical significance testing. There were notable improvements in all measured physical performance outcomes among program participants. Pairwise comparisons showed that the SPPB was significantly greater at 120 days ( M = 9.03, SE = 0.48), 90 days ( M = 7.66, SE = 0.41), 60 days ( M = 7.45, SE = 0.31) and at 30 days ( M = 6.39, SE = 0.29) compared to baseline ( M = 4.28, SE = 0.28). Significant improvement was also observed on the clinical frailty scale (F 3, 77.37 = 18 ,24, p < .01) with patients improving their frailty score from 5.67 (SE = 0.17) at baseline to 4.43 (SE = 0.28) after 90 days in the program. The VT program improved physical performance measures and decreased frailty in older adults. Expansion of home healthcare programs targeted to reverse frailty could provide increased access to an impactful intervention for this vulnerable population.

  • Open Access

    A Novel Home-Based Medication Management Program and Its Influence on Hospitalization Rates among Home Health Care Recipients

    by William R. Mills, Shauen Howard, Krystal Pitzen, Josh Smitherman, Laura Cole, Janine Wolfram, William Deane, Susan Sender, Dmitri Poltavski


  • Open Access

    Variation in Value-Based Outcome Measures Among Assisted Living Communities Served by a Home-Based Primary Care Practice During COVID-19

    by William R. Mills, Janet M. Buccola, Jamie Roosa, Lisa Lemin, Lynn Cappelli, Belinda Schraer

    We aimed to determine the hospitalization rate and average days spent at home in a population of assisted living (AL) residents served by a home-based primary care (HBPC) practice during the COVID-19 pandemic. We provided on-site HBPC to 1,699 AL residents and calculated hospitalization rate and days spent at home. The AL population had a mean age of 84 ± 10 years and 73% were female. The mean hospitalization rate was 449 admissions per 1,000 per year, and there was wide variation among AL communities. AL residents spent a mean of 358 days at home per year, and the average days spent at home varied during the COVID-19 pandemic. Use of these measures may help AL articulate its value proposition by enabling seniors with complex health needs to live in community settings for as many days as possible.

  • Open Access

    Home-Based Primary Care Led-Outbreak Mitigation in Assisted Living Facilities in the First 100 Days of Coronavirus Disease 2019

    by William R. Mills, Janet M. Buccola, Susan Sender, Joseph Lichtefeld, Nicholas Romano, Karen Reynolds, Melissa Price, Jennifer Phipps, Leigh White, Shauen Howard


  • Open Access

    Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID‐19 outbreak in the USA

    by W. R. Mills, S. Sender, J. Lichtefeld, N. Romano, K. Reynolds, M. Price, J. Phipps, L. White, S. Howard, D. Poltavski, et al.

    Background: It is unknown how the novel Coronavirus SARS‐CoV‐2, the cause of the current acute respiratory illness COVID‐19 pandemic that has infected millions of people, affects people with intellectual and developmental disability (IDD). The aim of this study is to describe how individuals with IDD have been affected in the first 100 days of the COVID‐19 pandemic.Methods: Shortly after the first COVID‐19 case was reported in the USA, our organisation, which provides continuous support for over 11 000 individuals with IDD, assembled an outbreak committee composed of senior leaders from across the health care organisation. The committee led the development and deployment of a comprehensive COVID‐19 prevention and suppression strategy, utilising current evidence‐based practice, while surveilling the global and local situation daily. We implemented enhanced infection control procedures across 2400 homes, which were communicated to our employees using multi‐faceted channels including an electronic resource library, mobile and web applications, paper postings in locations, live webinars and direct mail. Using custom‐built software applications enabling us to track patient, client and employee cases and exposures, we leveraged current public health recommendations to identify cases and to suppress transmission, which included the use of personal protective equipment. A COVID‐19 case was defined as a positive nucleic acid test for SARS‐CoV‐2 RNA.Results: In the 100‐day period between 20 January 2020 and 30 April 2020, we provided continuous support for 11 540 individuals with IDD. Sixty‐four per cent of the individuals were in residential, community settings, and 36% were in intermediate care facilities. The average age of the cohort was 46 ± 12 years, and 60% were male. One hundred twenty‐two individuals with IDD were placed in quarantine for exhibiting symptoms and signs of acute infection such as fever or cough. Sixty‐six individuals tested positive for SARS‐CoV‐2, and their average age was 50. The positive individuals were located in 30 different homes (1.3% of total) across 14 states. Fifteen homes have had single cases, and 15 have had more than one case. Fifteen COVID‐19‐positive individuals were hospitalised. As of 30 April, seven of the individuals hospitalised have been discharged back to home and are recovering. Five remain hospitalised, with three improving and two remaining in intensive care and on mechanical ventilation. There have been three deaths. We found that among COVID‐19‐positive individuals with IDD, a higher number of chronic medical conditions and male sex were characteristics associated with a greater likelihood of hospitalisation.Conclusions: In the first 100 days of the COVID‐19 outbreak in the USA, we observed that people with IDD living in congregate care settings can benefit from a coordinated approach to infection control, case identification and cohorting, as evidenced by the low relative case rate reported. Male individuals with higher numbers of chronic medical conditions were more likely to be hospitalised, while most younger, less chronically ill individuals recovered spontaneously at home.


  • Open Access

    An Outbreak Preparedness and Mitigation Approach in Home Health and Personal Home Care During the COVID-19 Pandemic

    by William R. Mills, Susan Sender, Karen Reynolds, Joseph Lichtefeld, Nicholas Romano, Melissa Price, Jennifer Phipps, Leigh White, Shauen Howard, Rexanne Domico

    The acute respiratory disease COVID-19, caused by the novel Coronavirus SARS-CoV-2, is a worldwide pandemic affecting millions of people. The methodology that organizations who provide home health and personal home care services are using to respond to this pandemic has not yet been characterized. In this report, we describe our approach to comprehensive outbreak suppression and report an initial case series of COVID-19 positive patients receiving home-based services. We implemented enhanced infection control procedures across our affiliates, and we communicated these protocols to our offices using multi-faceted methods. Using custom built software applications enabling us to track patient and employee cases and exposures, we leveraged current public health recommendations to identify cases and to suppress transmission. In the 100-day period between January 20, 2020 and April 30, 2020, our affiliates provided services to 67 COVID-19 positive patients (<0.3% of census). Twenty patients were referred to home health post hospitalization for COVID-19 related illness, whereas 47 were found to have COVID-19 while living in community settings. Of those who were found to have COVID-19 in the community, 17 (39%) required subsequent hospitalization. Hospitalized patients had an average age of 74.5 ± 18, and 53% were male. There were 13 deaths (76%) among those hospitalized from the community with COVID-19 related illness. A highly coordinated and frequently communicated approach to infection control, case identification and employee screening can be performed by home health and personal home care organizations. Studies that further assess risks and predictors of illness severity in home-based COVID-19 patients are needed.